- Merck Foundation conducts their post-training evaluation for their first graduate of ‘Merck Oncology Fellowship Program’ in Tanzania
- Merck Foundation commits to long-term partnership with Uganda minister of health through providing one and two years oncology fellowship in India, Egypt, and Malaysia for Ugandan doctors
- Following the ‘We Can. I can’ theme of ‘World Cancer Day 2016-18’ Merck Foundation commits to building cancer care capacity in Africa and developing countries
Merck Foundation (www.Merck-Foundation.com), a non-profit company and a subsidiary of Merck KGaA Germany (www.Merck.com) marks ‘World Cancer Day 2018’ to create awareness around cancer and build cancer care capacity with the aim to increase the limited number of oncologists across Africa and developing countries.
The CEO of Merck Foundation Dr. Rasha Kelej recently visited Muhimbili University of Health and Allied Science, Tanzania to meet the alumni of ‘Merck Oncology Fellowship Program’ with the aim to evaluate the impact of the one and two-year medical oncology fellowship programs conducted in Tata memorial center in India. Through ‘Merck Oncology Fellowship Program’ foundation has trained the first medical oncologist in Tanzania, Dr. Christina V. Malichewe.
During her visit to Tanzania Dr. Rasha Kelej emphasized, “We strongly believe that building professional capacity is the right strategy to improve access to quality and equitable cancer care in the continent. Dr. Christina is one of the 59 future oncologists, Merck Foundation has committed to train for Africa.”
In June 2017, BIO Ventures for Global Health (BVGH), and the African Organization for Research and Training in Cancer (AORTIC), released a white paper on the African continent’s emerging cancer crisis.
Over 20% of African countries have no access to cancer treatments at all, while access is limited and sporadic in other countries. Later-stage diagnosis in African patients contributes to poorer outcomes. For example, 5-year female breast cancer relative survival rates are 46% in Uganda and 12% in The Gambia, compared with around 90% in developed countries.
The first medical oncologist in Tanzania, Dr. Christina V. Malichewe said, “I can now make difference for my patients. We don’t have medical oncology to manage patients through chemotherapy, we only have clinical oncologists and radiotherapists. Thus, one-year medical oncology fellowship in India has enabled me to save many lives, every day. Thanks to Merck Foundation for this opportunity in Tanzania.”
During her meeting with Dr. Christina, Dr. Rasha Kelej said “I’ve enjoyed every moment with her, witnessing the great impact she makes every day on her patients’ lives. Through her, we transform people’s lives every day.”
Hon. Sarah Opendi, Uganda Minister of State of Health said, “Merck Foundation and ministry of health of Uganda have been partners for a very long time, we have been working together on various issues with special focus on cancer and infertility. We appreciate the efforts of Merck Foundation in building cancer care capacity in Uganda and other African countries, and we hope soon we would have world class cancer facilities and expert locally in our beloved country.”
The first fellow for ‘Merck Oncology Fellowship Program’ from Uganda Dr. Sekitene Seei Buwambaza said, “Merck Oncology Fellowship program is very important to me because it is giving me an opportunity to learn and improve on the way, I have been doing things concerning the management of cancer patients. It is also ushering me into the new trend that cancer care and research is taking in this 21st century. A bond with Merck Foundation as an alumnus is going to keep me updated with new developments in cancer care.”
Fellowship Program’ from Uganda, Dr. Musana Othiniel, an obstetrician and gynaecologist from Uganda, “Uganda as a country lacks a national cancer screening program yet cervical cancer and breast cancer remains the most common cancers and accounts for the highest proportion of cancers requiring treatment. The country also has a shortage of good gynae-oncology clinicians, researchers and educators in Uganda hence limiting access for women with cancer to screening, diagnostic and treatment services.”
He further added, “The ‘Merck Oncology Fellowship Program’ will expand my knowledge on the selection of appropriate clinical and research methodology used in gynae-oncology. I hope to improve my skills in carrying out appropriate and evidence-based clinical diagnosis and treatment but also empower me with excellent clinical education skill to mentor other young health workers in gynae-oncology.”
While Appreciating the efforts of Merck Foundation, Dr. Damas Dukundane, Merck Foundation oncology fellow from Rwanda said “When the right people are in charge then the right things happen. I am so excited to be part of this journey of change makers, where the history will remember us as the Merck Foundation fellows, who improved the lives of people with cancer in Africa, in the 21st century.”
Moreover, 50 future oncologists either joined or will join one, two or three years ‘Merck Oncology Fellowship Program’ from many sub-Saharan African countries out of which, countries such as Gambia and Liberia never had oncologists.
Merck Foundation will provide eight doctors from both Uganda and Tanzania with one -year medical oncology fellowship program. Furthermore, together with university of Nairobi, Merck Foundation established the first two-year medical oncology fellowship program for Sub-Saharan Africa.
Distributed by APO Group on behalf of Merck Foundation.
Join the conversation on our social media platforms below and let your voice be heard
Twitter: @Merckfoundation (https://goo.gl/Gj9Au1).
Join Merck Foundation healthcare & research online community to exchange experience and information with other healthcare providers, researchers, students, policy makers and community members in Africa and beyond
www.Merck-Foundation.com free registration
About Merck Foundation
The Merck Foundation (www.Merck-Foundation.com), established in 2017, is a philanthropic organization that aims to improve the health and wellbeing of people and advance their lives through science and technology. Our efforts are primarily focused on improving access to innovative healthcare solutions in underserved communities, building healthcare and scientific research capacity and empowering people in STEM (Science, Technology, Engineering, and Mathematics) with a special focus on women and youth. All Merck Foundation press releases are distributed by e-mail at the same time they become available on the Merck Foundation Website. Please go to www.Merck-Foundation.com to read more and/or register online to interact and exchange experience with our registered members.
Merck Foundation is a subsidiary of Merck KGaA Germany
Merck (www.Merck.com) is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.
Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
By CNBC Africa